Faculty profile

Adam Komorowski

Back to faculty
Assistant ProfessorMedicineMcMaster University

Research

Dr. Adam S. Komorowski is a Canadian-Italian infectious diseases consultant, medical microbiologist, methodologist, and Assistant Professor in the Division of Infectious Diseases, Dept. of Medicine with a cross-appointment to the Dept. of Pathology and Molecular Medicine (PMM). Within PMM, Adam serves as the program director for the medical microbiology fellowship program. He completed a BSc in microbiology and immunology at the University of Toronto, his medical degree in Ireland, and his medical microbiology residency and MSc in Health Research Methodology (advisor: Dr. D. Mertz) at McMaster University, where his thesis focused on using whole genome sequencing to study Serratia marcescens complex transmission. From 2024-2026, Adam studied non-pharmacologic pandemic interventions through a fellowship with the Pandemic EVIDENCE Collaboration at Kellogg College, University of Oxford. Adam's research programme broadly focuses on using evidence-based medicine to improve the diagnosis and treatment of infectious diseases, with special interests in invasive fungal infections and diagnostic test accuracy study methodology. He is an active principal investigator/co-investigator on multiple CIHR-funded studies and has published over 40 peer-reviewed papers, including guidelines co-authored with the Ontario COVID-19 Science Advisory Table. Adam's other roles include serving as an associate deputy editor of Open Forum Infectious Diseases, as well as membership in the editorial board of the Journal of Clinical Microbiology and the editorial advisory board of Clinical Infectious Diseases. Dr. Komorowski is NOT ACCEPTING requests to supervise graduate students or undergraduate thesis projects, and is unable to reply to such requests.  Dr. Komorowski IS ACCEPTING inquiries from qualified medical students and medical residents for voluntary research assistant roles in infectious diseases, medical microbiology, and/or research methodology.

Research areas, by share of publications

Research areas are derived from OpenAlex topics of their publications.

41 publications.

01

Daptomycin and linezolid salvage therapy for persistent ampicillin-susceptible Enterococcus faecalis bacteremia in a patient with possible anaphylaxis to β-lactam and glycopeptide antimicrobials: A case report.

Phuong N, Collins J, Li LX, Messieh M, Drucker Iarovich M, Blankstein U, Komorowski AS

JAMMI20261 citationsSenior author
02

RE: Impact of beta-blockers on prognostic outcomes in solid cancers: a systematic review and meta-analysis

Sharma A, Komorowski AS, Jerzak KJ

Journal of the National Cancer Institute20261 citations
03

Skeletal muscle candidiasis presenting as degenerative pathology with partial dissolution of myofibers

Lam C, Bellini J, Grant S, Komorowski AS, Lu J-Q

Neurological Sciences2026
04

The Impact of Beta Blockers on Survival in Cancer Patients: A Systematic Review and Meta-Analysis

Sharma AE, Chan S, Komorowski AS, Cao X, Gao Y, Kshatri K, Desai K, Kuksis M, Rosen M, Sachdeva A

Cancers202520 citations
05

Molecular Epidemiology of Clinical Infections Caused by Serratia marcescens Complex in a Tertiary Care Hospital System: Insights From Whole-Genome Sequencing

Komorowski AS, Surette MG, Rossi L, Tertigas D, Gaskin M, Shekarriz S, McArthur AG, Smieja M, Mertz D

Journal of Infectious Diseases20253 citationsFirst author
06

Detection of non-travel-associated, ceftriaxone non-susceptible Neisseria gonorrhoeae FC428-like harbouring the mosaic penA60 allele in Ontario, Canada

Komorowski AS, Eshaghi A, Burbidge J, Johnson K, Saunders A, Zygmunt A, Hasso M, Almohri H, Martin I, Patel SN

Canada Communicable Disease Report20251 citationsFirst author
07

AeroVax: study protocol for a randomised, double-blind, placebo-controlled, phase 2 trial to evaluate safety and immunogenicity of a next-generation COVID-19 vaccine delivered by inhaled aerosol to humans

Komorowski AS, Mbuagbaw L, Jeyanathan M, Afkhami S, Swinton M, D'Agostino MR, Howie K, Medina MFC, Gauvreau GM, Brister DL

ERJ Open Research20251 citationsFirst author
08

Abstract P4-12-30: The Impact of Beta Blocker Use on the Survival of Cancer Patients: A Systematic Review and Meta-Analysis

Chan S, Komorowski A, Cao X, Gao Y, Kshatri K, Desai K, Kuksis M, Rosen M, Sachdeva A, Kojundzic I

Clinical Cancer Research2025
09

Cerebrospinal fluid galactomannan detection for the diagnosis of central nervous system aspergillosis: a diagnostic test accuracy systematic review and meta-analysis

Komorowski AS, Hall CW, Atwal S, Johnstone R, Walker R, Mertz D, Piessens EA, Yamamura D, Kasper EM

Clinical Microbiology and Infection (CMI)202422 citationsFirst author
10

Verification, Analytical Sensitivity, Cost-effectiveness, and Comparison of 4 Candida auris Screening Methods

Komorowski AS, Aftanas P, Porter V, Katz K, Kozak RA, Li XX

Open Forum Infectious Diseases202418 citationsFirst authorOpen Access

Research institutes and memberships

  • Michael G. DeGroote Institute for Infectious Disease Research (IIDR)
Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for
Subject: Prospective PhD student: Meta-analysis and systematic reviews Dear Professor Komorowski, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Daptomycin and linezolid salvage therapy for persistent ampicillin-susceptible Enterococcus faecalis bacteremia in a patient with possible anaphylaxis to β-lactam and glycopeptide antimicrobials: A case report." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]
Open in email
Something wrong or missing on this profile? Suggest a correction